Organic compounds -- part of the class 532-570 series – Organic compounds – Four or more ring nitrogens in the bicyclo ring system
Reexamination Certificate
2011-06-28
2011-06-28
Lundgren, Jeffrey S (Department: 1613)
Organic compounds -- part of the class 532-570 series
Organic compounds
Four or more ring nitrogens in the bicyclo ring system
C544S240000, C544S241000, C546S210000
Reexamination Certificate
active
07968711
ABSTRACT:
The present invention provides a method of treating glaucoma or ocular hypertension which comprises applying to the eye of a person in need thereof an amount sufficient to treat glaucoma or ocular hypertension of a compound of formula Iwherein Y, Q, Z, R, R1and R2are as defined in the specification.The present invention further comprises pharmaceutical compositions, e.g. ophthalmic compositions, including said compound.
REFERENCES:
patent: 3281424 (1966-10-01), Doebel et al.
patent: 2002/0137961 (2002-09-01), Bradley et al.
patent: 2002/0161041 (2002-10-01), Browning et al.
patent: 2003/0180234 (2003-09-01), Love et al.
patent: 2005/0282902 (2005-12-01), Chen et al.
patent: 2005/0282912 (2005-12-01), Chen et al.
patent: 2005/0282913 (2005-12-01), Chen et al.
patent: 0119087 (1984-09-01), None
patent: 0 210 647 (1986-07-01), None
patent: 0492904 (1992-07-01), None
patent: 1384304 (1964-11-01), None
patent: 917849 (1963-02-01), None
patent: WO03/068230 (2003-08-01), None
patent: WO 03/091189 (2003-11-01), None
patent: WO 2005/007632 (2005-01-01), None
patent: WO2005/007632 (2005-01-01), None
patent: WO 2006/001982 (2006-01-01), None
patent: WO 2006/007227 (2006-01-01), None
patent: WO 2007/008548 (2007-01-01), None
patent: WO2007/014226 (2007-01-01), None
patent: WO2007/014226 (2007-02-01), None
Wei-dong Liu, et al, Synthesis and Biological Activity of Methyl N-methoxy-N-[2-substituent-4-chloro-3(2H)-pyridazinone-5-yl-oxymethyl (or mercaptomethyl)phenyl] carbamates, 13 Hecheng Huaxue 33 (2005).
Lidia Moreira Lima & Eliezer J. Barreiro, Bioisosterism: A Useful Strategy for Molecular Modification and Drug Design, 12 Curr. Med. Chem. 23 (2005).
V. Konecny, Pyridazinones. I. Preparation of 2,4-disubstituted 5-hydroxy-3(2H)-pyridazinones and 2,5-disubstituted 4-hydroxy-3(2H)-pyridazinones, 30 Chem. Zvesti. 663, 664-69 (1975).
J. Zuziova, et al, Synthesis and Pesticidal Activity of 2,4-disubstituted O-(haloalkyl)-O-(alkyl, Aryl)-(N-Alkylamido, N,N-dialkylamido)-O-(3-oxo-2H-pyridazine-5-yl) Esters of Thiophosphoric Acid, 42 Chem. Papers. 415 (1988).
Yoshifumi Maki & Masahiko Takaya, The Ring Contraction of Pyridazinones to Pyrazoles, 19 Chem. Pharm. Bull. 1635, 1638 (1971).
V. Konecny, Pyridazinones. I. Preparation of 2,4-disubstituted 5-hydroxy-3(2H)-pyridazinones and 2,5-disubstituted 4-hydroxy-3(2H)-pyridazinones, 30 Chem. Zvesti. 663, 664-69 (1975).
Yoshifumi Maki & Masahiko Takaya, The Ring Contraction of Pyridazinones to Pyrazoles, 19 Chem. Pharm. Bull. 1635, 1638 (1971).
Kd. Meier, et al, Chemotherapeutic Studies in the Heterocyclic Series. VII. Pyridazines. 4. Derivatives of Cyclic Chloromaleic Phenylhydrazides, 37 Helv. Chim. Acta .523 (1954).
Wei-dong Liu, et al, Synthesis and Biological Activity of Methyl N-methoxy-N-[2-substituent-4-chloro-3(2H)-pyridazinone-5-yl-oxymethyl (or mercaptomethyl)phenyl] carbamates, 13 Hecheng Huaxue 33 (2005).
Lidia Moreira Lima & Eliezer J. Barreiro, Bioisosterism: A Useful Strategy for Molecular Modification and Drug Design, 12 Curr. Med. Chem. 23 (2005).
Pisanenko et al, “Anti Microbial Activity of Cyclo Alkenyl Phenos and 4-Alpha Arylcyclopentyl Phenols”, Pharmaceutical Chemistry Journal, vol. 10, No. 10, 1997.
Adams et al, “Structure of Cannabidiol. IV. The position of the linkage between the two rings”, J. Am. Chem. Soc., vol. 62, pp. 1774-1775, 1940.
Fujikawa et al, Antiseptics for foods. LXXIII. 3-Halo-4-hydroxy benzoic acid esters, 4-alkylresorcinol, 4-arylresorcinol, . . . , Chemical Abstracts Database, XP00244503, 1972.
Arnoldi et al, “Analogues of Cannabinoids, Synthesis of N-Heterocyclic Derivatives of Olivetol”, J. Chem., XP009087450, 1983.
Yorio et al, “New therapies for glaucoma: Are they all up to the task?”, Expert Opinion on Therapeutic Patents 2004, vol. 14, No. 12, pp. 1743-1762, 2004.
Howlett et al, “International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors”, Pharmacological Reviews, 54: 2002, pp. 161-202.
Cieplak et al, “Reversal of π-Facial Diastereoselection upon Electronegative Substitution of the Substrate and the Reagent”, J. Am. Chem. Society, 1989, 111, pp. 8447-8462.
Micovic et al, “The synthesis of lactam analogues of fentanyl”, J. Chem. Soc., Perkin Trans 1, 1996, pp. 2041-2050.
Wagner et al, “Mesenteric Vasodilation Mediated by Endothelial Anandamide Receptors”, Hypertension. 33 [part II], 1999, pp. 429-434.
Jarai et al, Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors, PNAS, vol. 96, No. 24, 1999, pp. 14136-14141.
McNamara et al, “Synthesis, antitumor activity, and antiviral activity of 3-substituted 3-deazacytidines and 3-substituted 3-deazauridines”, Journal of Medicinal Chemistry, vol. 33, No. 7, pp. 2006-2011, 1990.
Katz et al, “Synthesis of pyridazine analogues of the naturally occurring nucleosides cytidine, uridine, deoxycytidine, and deoxyuridine”, Journal of Medicinal Chemistry, vol. 25, No. 7, pp. 812-821, 1982.
Konecny et al, “Synthesis, Spectral Properties, and Pesticidal Activity of 4-Amino(Alkylamino, Dialkylamino)-5-Chloro-2-Substituted-3-Oxo-2H-Pyr Idazines and 5-Amino(Alkylamino, Dialkylamino)-4-Chloro-2-Substituted 3-Oxo-2H-Pyridazines”, Collection of Czechoslovak Chemical Communications, pp. 492-502, 1985.
Schober et al, “Pyridazines with heteroatom substituents in positions 3 and 5.6 SN Reactions in position 5 of 2-aryl-5-hydroxypridazin-3(2H)-ones”, Journal of Heterocyclic Chemistry, vol. 27, No. 3, pp. 471-477, 1990.
McElvan et al, “Ketene Acetals. XII. The reaction of ketene diethylacetal with diazonium salts”, Journal of the American Chemical Society, p. 2238, 1943.
Konecny, “Pyridazinones. I. Preparation of 2, 4-disubstituted 5-hydroxy-3(2H)-pyridazinones and 2,5-disubstituted 4-hydroxy-3(2H)-pyridazinones”, Chemick Zvesti-Chemical Papers, vol. 30, pp. 663-673, 1976.
Liu et al, “Synthesis and biological activity of methyl N-methoxy-N-[2-substituent-4-chloro-3(2H)-pyridazinone-5-yl-oxymethyl(or mercaptomethyl)phenyl]carbamates”, Database accession No. 2005-274821, 2005.
Zuziova et al, “Synthesis and pesticidal activity of 2,4-disubstituted 0-(haloalkyl)-O-(alkyl, aryl)-(N-alkylamido, N,N-dialkylamido)-)-(3-oxo-2H-pyridazine-5-yl)esters of thiophospornic acid”, Database accession No. 1989:114966.
Baloniak et al, “Synthesis of the derivatives of 1-(2-and 3-methylphenyl)-3-hydroxy-6-pyridazinones”, Database accession No. 1983:453681.
Miyake et al, “Pyridazinone Derivative andController Against Insect Pest”, Database accession No. 118957-78-1, 1988.
Cho et al, “Novel synthesis of pyridazino[4,5-b][1,4]oxazin-3,8-diones”, Tetrahedron Letters, vol. 44,No. 50, 2003.
Bekhli et al, “Structure of the products of the cyclization in actic anhydride of ?-(2-carboxy-5-chlorophyenylamino)propionic acid andits nitrile”, Chmistry of Heterocyclic Compounds, vol. 6, No. 7, pp. 814-819, 1970.
Asahi et al, “Manganese(III)-based oxidation of 2,4-piperidinediones in the presence of alkenes”, Tetrahedron, vol. 61, No. 47, pp. 11107-11124, 2005.
Micovic et al, “The Synthesis of Lactam Analogues of Fentanyl”, Journal of the Chemistry Society, pp. 2041-2050, 1996.
Gegner, “Synthesis of 1-phenyl-3-3thy1-4-hydroxy-2(1H)-pyridone”, Tetrahedron Letters, pp. 287-8, 1969.
Tomisawa, “1-Alkyl-2-pyridone derivatives I. Sandmyer reaction of 1-phenethyl-4(or 5)-amino-2-pyridone”, Database accession 1960:16966.
Hirohashi et al, “Synthesis of 5-fluorouracil derivatives containing an inhibitorof 5-fluorouracil degradation”, Chemical and Pharmaceutical Bulletin, vol. 41, No. 9, pp. 1498-1506, 1993.
Chen June
Fliri Hans G.
Pettit Simon N.
Allergan Inc.
Allergan, Inc.
Basquill Sean
Condino Debra D.
German Joel B.
LandOfFree
Abnormal cannabidiols as agents for lowering intraocular... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Abnormal cannabidiols as agents for lowering intraocular..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Abnormal cannabidiols as agents for lowering intraocular... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2688933